Minimal literature exists investigating changes in inflammation with respect to the main nasal cavity (MNC) and paranasal sinuses (PS) before and after maximal medical therapy (MMT) for chronic rhinosinusitis (CRS). We hypothesized that MMT produces a differential level of change in the volume of air space in the MNC and PS, and that resolution of mucosal disease associated with the osteomeatal complex (OMC) influences clinical response to MMT.
Introduction
Before consideration of functional endoscopic sinus surgery (FESS), it is generally accepted that patients with chronic rhinosinusitis (CRS) undergo a trial of "maximal medical therapy" (MMT). [1] [2] [3] Although variation exists with regard to the definition and duration of MMT, the mainstay of treatment focuses on oral antibiotics, topical intranasal steroids, and sinonasal saline irrigation, with possible systemic oral steroid therapy. [1] [2] [3] In a survey, greater than half of otolaryngologists who responded used sinonasal saline irrigation, intra-nasal steroids, oral steroids, and oral antibiotics with widely varying treatment durations in greater than 50% of patients presenting for initial evaluation of CRS. 1 Though many studies have confirmed the efficacy of MMT in the management of CRS, there is no agreed upon consensus regarding the most effective regiment. [4] [5] [6] [7] The goals in the treatment of CRS are reduction in inflammation of the sinonasal mucosa, improved mucociliary clearance of the paranasal sinuses, and enhanced sinonasal airflow through the main nasal cavity with associated improvement in clinical symptoms. 2, 4, [8] [9] [10] [11] Currently, there are a number of studies that have investigated the effect of FESS on the sinonasal cavity and implications for nasal irrigation and drug delivery.
According to Wofford et al., who studied the effect of FESS on topical maxillary sinus drug delivery, FESS with larger maxillary antrostomies allowed for improved topical drug delivery. 12 Additionally, Frank et al. confirmed the enhancement in airflow particularly in the maxillary sinus that was associated with improvement in patient quality of life as well based on symptom questionnaires. 13 The majority of literature in the study of the sinonasal cavity of CRS patients has primarily focused on pre-and post-surgical evaluation of the main nasal cavity (MNC) and paranasal sinuses (PS). However, scant literature exists investigating changes in the MNC and PS before and after MMT for CRS, and whether such changes are differential .
In addition, it is unclear whether certain disease patterns influence clinical success or failure of MMT. According to Lal et al., clinical predictors of failure of medical therapy for patients with CRS included higher patient scores of facial pressure and significant endoscopic mucosal inflammation. 4 However, given that computed-tomography (CT)
analysis generally provides the most comprehensive and objective method of assessing sinonasal disease severity, assessment of sinus CT's can often provide important information regarding change after treatment intervention.
14 Therefore, we sought to differentially compare and analyze changes in the MNC and PS using three-dimensional (3D) reconstructed models of sinus CT scans of patients obtained before and after MMT for CRS. In this preliminary study of six patients, we hypothesized that there is a differential level of change in the volume of air space and mucosal inflammation in the nasal cavity when compared to the paranasal sinuses, and that these volumes of change distinctively impact the overall change in air space after medical therapy. Secondly, we hypothesized that resolution of mucosal disease associated with the osteomeatal complex (OMC) influences clinical response to MMT and direct visualization of the OMC from the external nares may be associated with success of MMT.
Materials and Methods
After approval from the Institutional Review Board, sinus-CT scans from subjects with CRS who had been treated with MMT were obtained. Patients from the subject pool had been diagnosed with CRS based on clinical criteria and none had prior surgical therapy. 9 Of note, patients in the subject pool were previously enrolled in a prospective, randomized cohort study evaluating MMT, however this study is a retrospective analysis of the sinus CT scans that were obtained as part of the prior study protocol. 5 MMT for these patients was defined as an oral antibiotic course, intra-nasal steroid treatment with A total of 12 CT scans were chosen for this preliminary evaluation. Of these 12 scans, 6 sinus CT scans represented pre and post-therapy scans from patients who were deemed clinically successful responders to MMT. Conversely, the remaining 6 sinus CT scans represented pre-and post-therapy scans from patients who were deemed clinical failures to MMT and would require surgical intervention.
Successful response or failure to MMT was determined based on clinical decision utilizing subjective and objective scoring measures including RSDI and LM scores, in addition to global patient symptoms.
Next, Mimics 18.1™ (Materialise, Inc., Plymouth, MI, USA) was used to create anatomically realistic three-dimensional (3D) reconstructions of the MNC and PS airways from the pre-and post-therapy CT scans. In each scan, the airspace was selected by setting a maximum threshold of -300 to -351 Hounsfield units based on visual inspection. The resulting pixel selection was then hand-edited to achieve anatomical accuracy and to separate the PS from the MNC (Fig. 1) . Volumetric analysis was then performed on the nasal air spaces of the pre-and post-therapy sinus CT 3D models, as a negative correlate of airway obstruction, purulence, and swelling associated with mucosal inflammation. Of note, prior to the volumetric study, the effect of nasal cycling in the CT 
Results
The selected cohort included three clinical successes and three clinical failures of MMT for CRS. RSDI and LM scores worsened or remained the same after MMT in three subjects (Table 1) . Conversely, RSDI and LM scores overall improved or remained the same after MMT in three subjects (Table 1) . Importantly, all failure patients in the cohort required FESS to address CRS symptoms.
There was a mean increase in the sinonasal airspace volume in the clinical success group when combining the volume of the MNC and PS and a mean decrease in the clinical failures group (Tables 2, 3 ). Using 3D reconstructive techniques, this change was captured and used to analyze the MNC and PS separately (Fig, 2) . In the three failures, there was an average decrease in the airspace volume of the MNC and PS of 4043.4 ± 3092.9 and 4118.7 ± 6331.5, respectively (Table 3 ). In the three successes, there was an average increase in the airspace volume of the MNC and PS of 3805.8 ± 8046.0 and 13701.5 ± 17574.8, respectively (Table 3) . Of note, in each outcome group, two of the three subjects had consistent and expected directions of volume change of the MNC and PS. However, in each outcome group, there was one subject whose direction of volume of change in the MNC and PS diverged with respect to the overall change in the sinonasal airspace volume. In the success group, the volumetric analysis of subject 6, whose total sinonasal volume increased, demonstrated an unexpected decrease in the MNC volume, and in the failure group, the volumetric analysis of subject 1, whose total sinonasal airspace volume decreased, demonstrated an unexpected increase in the PS volume ( From the overlay analysis, OMC patency was achieved or there was noticeable reduction in inflammation surrounding the complex itself in the success group (Fig. 3A) .
However, despite MMT, there was worsening of mucosal obstruction at the OMC or no improvement in mucosal inflammation surrounding the OMC in the three failures (Fig.   3B ).
Visualization of the OMC using digitally created "line-of-sight" demonstrated that successful responders to MMT had more patent MNC with direct access to the OMC (Fig. 4) . The three patients with medical success had line-of-sight scores of 2, 5, and 7
with an average score between the three of 4.67 (Table 4) . As anticipated, those who failed medical management had higher line-of-sight scores of 6, 9, and 9 with an average score of almost double, 8.0 (Table 4) .
Discussion
Although there is a general consensus that MMT should be attempted prior to consideration of FESS, a recent systematic review showed that there is no definitive guideline on what constitutes MMT and only 21% of included studies demonstrated explicit MMT criteria that are necessary to fail prior to offering FESS. 8 Additionally,
though there is demonstrated benefit, the direct impact of MMT on the sinonasal cavity remains unclear. 11 In conjunction, few studies have addressed differential impact of medical therapy for CRS on the MNC when compared to PS, and whether certain disease patterns lead to more medically refractory disease. However, once the PS were separated from the MNC, there appeared to be an interesting divergence in findings in addition to differential impact of each the MNC and PS to the overall volume change.
First, amongst the success group, the direction of volume change of the PS and MNC was congruent with the general increase in overall sinonasal volume in two subjects. However, even amongst these two subjects, there is a notable difference in how much PS compared to the MNC volume change contributes to the overall sinonasal volume change, wherein one subject the PS volume change is the dominant factor compared the MNC volume change being the dominant factor for the other patient.
When comparing the pre and post-therapy LM and RSDI scores for these patient, there appeared to be a greater improvement in the RSDI score for the patient whose PS volume change seemed to be primary driver of sinonasal volume increase compared to the other patient in MNC volume change was the primary driver. Interestingly, in the third success patient with diverging changes, whose PS volume increased while the MNC volume decreased, the total sinonasal volume change was lower, however, the patient's symptom scores on the RSDI demonstrated significant improvement. Although limited by sample size, this data suggests that there may be a differential impact of MMT on the PS and MNC. Given incongruity amongst the patients' changes, it is difficult to state whether changes in the MNC vs. the PS have a more clinical impact on response to MMT.
Similarly, in the failure group, the direction of volume change of the PS and MNC was congruent with the general decrease in overall sinonasal volume in two subjects.
Again, even amongst these two subjects, there is a notable difference in how much PS compared to the MNC volume change contributes to the overall sinonasal volume change. Interestingly amongst these two subjects, there was no difference in the pre-and post-therapy LM scores, showing that the sensitivity of the LM score to subtle sinonasal changes is lower. The third patient of the failure cohort also interestingly demonstrated diverging changes in the volume of the MNC compared to the PS with respect to overall sinonasal volume change, wherein there was a small increase in PS volume compared to a larger decrease in MNC volume that was the primary driver. This data demonstrates differential impact of MMT on the MNC vs. the PS, but without significant antecedent literature investigating the direct impact of MMT on the sinonasal cavity, it is difficult to assess how this impacts response to medical treatment.
The osteomeatal complex plays a pivotal role in CRS given its physiologic function as a common, sinus drainage pathway and association with increased disease burden. 15 Importantly, there are limitations to note. Given the small sample size in both cohorts, it is difficult to make population based inferences about responsiveness to MMT.
Secondly, when separating the PS from the MNC, there is no standardized method of separating sinuses from the nasal cavity, thus there is some variability noted between 3D reconstructions. After denoting differential change in the MNC and PS volume in patients after MMT for CRS, the next step in elucidating the effect of MMT on the sinonasal cavity is to perform computational fluid dynamics (CFD) analysis on these patients' CD. 12, 16 Through CFD, differential change on the nasal airflow within the MNC and PS can be studied to determine if MMT has a direct impact on nasal airflow and how clinical responders differ from clinical failures.
Conclusion
This study demonstrated that MMT has a definitive impact on changes in the 
